Reasons for use and non-use of the pertussis vaccine during pregnancy: an interview study
Natalie J. Gauld 1 2 , Crystal S. Braganza 1 , Ola O Babalola 1 , Tung T Huynh 1 , Sarah M Hook 11 School of Pharmacy, University of Otago, Dunedin, New Zealand
2 Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand
Correspondence to: Dr Natalie J. Gauld, Department of General Practice and Primary Health Care, Morrin Rd, St Johns, Auckland 1072, New Zealand. Email: n.gauld@auckland.ac.nz
Journal of Primary Health Care 8(4) 344-350 https://doi.org/10.1071/HC15049
Published: 21 December 2016
Journal Compilation © Royal New Zealand College of General Practitioners 2016.
This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abstract
INTRODUCTION: In New Zealand, pertussis vaccination is recommended and government-funded during every pregnancy to protect the infant after birth. However, uptake is low and needs to be increased.
AIM: To investigate enablers and barriers for uptake of the pertussis vaccination by pregnant women in New Zealand, and explore the acceptability of provision in pharmacies.
METHODS: Women with infants were recruited in selected pharmacies and interviewed using a brief structured interview. Transcripts were analysed using a framework approach.
RESULTS: Thirty-seven women aged 18–43 years provided data for analysis. Seventeen women reported receiving a pertussis vaccination during their pregnancy. Information from health professionals appeared important to encourage vaccination, but other sources of information (eg antenatal groups and media) were also cited. Non-vaccination arose from being unaware of the need for pertussis vaccination during pregnancy, concerns about safety, and misinformation. Participants supported pertussis vaccination in pharmacies to help access or increase the opportunity for health professionals to inform women.
DISCUSSION: The information received by participants affected their uptake of the pertussis vaccine during pregnancy. Education of the public and health professionals about the pertussis vaccine during pregnancy is necessary.
References
[1] Ministry of Health. Immunisation Handbook. Wellington, New Zealand: Ministry of Health; 2014.[2] Somerville RL, Grant CC, Grimwood K, et al. Infants hospitalised with pertussis: estimating the true disease burden. J Paediatr Child Health. 2007; 43 617–22.
| Infants hospitalised with pertussis: estimating the true disease burden.Crossref | GoogleScholarGoogle Scholar |
[3] Grant CC. Recent indication of progress in pertussis hospitalisation rates in New Zealand. Aust N Z J Public Health. 2012; 36 398
| Recent indication of progress in pertussis hospitalisation rates in New Zealand.Crossref | GoogleScholarGoogle Scholar |
[4] Grant CC, Reid S. Pertussis continues to put New Zealand’s immunisation strategy to the test. N Z Med J. 2010; 123 46–61.
[5] Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014; 384 1521–8.
| Effectiveness of maternal pertussis vaccination in England: an observational study.Crossref | GoogleScholarGoogle Scholar |
[6] Anonymous . Pertussis immunisation in pregnancy. Best Pract J. 2014; 60 34–7.
[7] Cheng PJ, Huang SY, Shaw SW, et al. Factors influencing women’s decisions regarding pertussis vaccine: A decision-making study in the Postpartum Pertussis Immunization Program of a teaching hospital in Taiwan. Vaccine. 2010; 28 5641–7.
| Factors influencing women’s decisions regarding pertussis vaccine: A decision-making study in the Postpartum Pertussis Immunization Program of a teaching hospital in Taiwan.Crossref | GoogleScholarGoogle Scholar |
[8] Varan AK, Esteves-Jaramillo A, Richardson V, et al. Intention to accept Bordetella pertussis booster vaccine during pregnancy in Mexico City. Vaccine. 2014; 32 785–92.
| Intention to accept Bordetella pertussis booster vaccine during pregnancy in Mexico City.Crossref | GoogleScholarGoogle Scholar |
[9] Urwyler P, Heininger U. Protecting newborns from pertussis – the challenge of complete cocooning. BMC Infect Dis. 2014; 14 397
| Protecting newborns from pertussis – the challenge of complete cocooning.Crossref | GoogleScholarGoogle Scholar |
[10] Frère J, De Wals P, Ovetchkine P, et al. Evaluation of several approaches to immunize parents of neonates against B. pertussis. Vaccine. 2013; 31 6087–91.
| Evaluation of several approaches to immunize parents of neonates against B. pertussis.Crossref | GoogleScholarGoogle Scholar |
[11] Donaldson B, Jain P, Holder BS, et al. What determines uptake of pertussis vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London. Vaccine. 2015; 33 5822–8.
| What determines uptake of pertussis vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London.Crossref | GoogleScholarGoogle Scholar |
[12] Wiley KE, Cooper SC, Wood N, Leask J. Understanding pregnant women’s attitudes and behavior toward influenza and pertussis vaccination. Qual Health Res. 2015; 25 360–70.
| Understanding pregnant women’s attitudes and behavior toward influenza and pertussis vaccination.Crossref | GoogleScholarGoogle Scholar |
[13] Calder K, Bidwell S, Brunton C, Pink R. Evaluation of the Canterbury under-18 seasonal influenza vaccination programme. N Z Med J. 2014; 127 19–27.
[14] Poole T, Goodyear-Smith F, Petousis-Harris H, et al. Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities. Vaccine. 2012; 31 84–88.
| Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities.Crossref | GoogleScholarGoogle Scholar |
[15] Grabenstein JD, Guess HA, Hartzema AG, , et al. Effect of vaccination by community pharmacists among adult prescription recipients. Med Care 2001; 39 340–8.
| Effect of vaccination by community pharmacists among adult prescription recipients.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3MzgslOjsA%3D%3D&md5=bf43d3bbf8555231c5fb07d936b7021cCAS |
[16] Steyer TE, Ragucci KR, Pearson WS, Mainous AG . The role of pharmacists in the delivery of influenza vaccinations. Vaccine. 2004; 22 1001–6.
| The role of pharmacists in the delivery of influenza vaccinations.Crossref | GoogleScholarGoogle Scholar |
[17] Warner JG, Portlock J, Smith J, Rutter P. Increasing seasonal influenza vaccination uptake using community pharmacies: experience from the Isle of Wight, England. Int J Pharm Pract. 2013; 21 362–67.
| Increasing seasonal influenza vaccination uptake using community pharmacies: experience from the Isle of Wight, England.Crossref | GoogleScholarGoogle Scholar |
[18] Hook S, Windle J. Community pharmacy influenza immunisation increases vaccine uptake and gains public approval. Aust N Z J Public Health. 2013; 37 489–90.
| Community pharmacy influenza immunisation increases vaccine uptake and gains public approval.Crossref | GoogleScholarGoogle Scholar |
[19] Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000; 320 114–6.
| Qualitative research in health care. Analysing qualitative data.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c%2FptVOgug%3D%3D&md5=9c59ae6a84debab652c5bfa2e24d9892CAS |
[20] Beel ER, Rench MA, Montesinos DP, et al. Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother. 2013; 9 1926–31.
| Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period.Crossref | GoogleScholarGoogle Scholar |
[21] Hayles EH, Cooper SC, Wood N, et al. Pertussis booster vaccination in pregnancy: women who had it compared to those who waited. Procedia Vaccinol. 2015; 9 59–65.
| Pertussis booster vaccination in pregnancy: women who had it compared to those who waited.Crossref | GoogleScholarGoogle Scholar |
[22] Wiley KE, Massey PD, Cooper SC, et al. Pregnant women’s intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine. 2013; 31 3972–8.
| Pregnant women’s intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3sjjs1Shsw%3D%3D&md5=ac1ef6e5931e09039d0055bc7fcf9884CAS |
[23] Webb H, Street J, Marshall H. Incorporating immunizations into routine obstetric care to facilitate health care practitioners in implementing maternal immunization. Hum Vaccin Immunother. 2014; 10 1114–21.
| Incorporating immunizations into routine obstetric care to facilitate health care practitioners in implementing maternal immunization.Crossref | GoogleScholarGoogle Scholar |
[24] Healy CM, Ng N, Taylor RS, et al. Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center. Vaccine. 2015; 33 4983–7.
| Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center.Crossref | GoogleScholarGoogle Scholar |
[25] Mills C. Invasive meningococcal disease in Northland, New Zealand. N Z Med J. 2011; 124 95–7.
[26] Petousis-Harris H, Grant CC, Goodyear-Smith F, et al. What contributes to delays? The primary care determinants of immunisation timeliness in New Zealand. J Prim Health Care. 2012; 4 12–20.
[27] Clarke C, Wall GC, Soltis DA. An introductory pharmacy practice experience to improve pertussis immunization rates in mothers of newborns. Am J Pharm Educ. 2013; 77 29
| An introductory pharmacy practice experience to improve pertussis immunization rates in mothers of newborns.Crossref | GoogleScholarGoogle Scholar |
